Department of Pharmaceuticals announces the Revamped Pharmaceuticals Technology Upgradation Assistance Scheme
Department of Pharmaceuticals announces the Revamped Pharmaceuticals Technology Upgradation Assistance Scheme
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers is announce the Revamped Pharmaceuticals Technology Upgradation Assistance (RPTUAS) Scheme. It is a significant step in government’s efforts to help upgrade the technological capabilities of our pharmaceutical industry and ensure its alignment with the global standards.
The approval of the revised Scheme follows a comprehensive review by the Scheme Steering Committee in light of the requirements of the revised Schedule-M of the Drugs and Cosmetics Rule, 1945 as issued by the Department of Health & Family Welfare on 28/12/2023. The revised guideline aims to support the pharmaceutical industry’s up-gradation to the Revised Schedule-M & WHO-GMP standards, enhancing the quality and safety of pharmaceutical products manufactured in our country.
Key Features of the Revised Scheme:
Turnover
Incentives
(i) Turnover less than Rs. 50.00 crore
20% of investment under eligible activities
(ii)Turnover from Rs. 50.00 crore to less than Rs. 250.00 crore
15% of investment under eligible activities;
(iii) Turnover from Rs. 250.00 crore to less than Rs. 500.00 crore
10% of investment under eligible activities.
Department of Pharmaceuticals is confident that reform in the PTUAS Scheme will contribute to pharmaceutical industry’s growth and compliance with global manufacturing standards. The revamped Scheme underscores government’s commitment to supporting the pharmaceutical industry which is critical to the nation’s health and well-being.